about
Current status of active surveillance in prostate cancerClinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label StudyRenal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage.Feasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years.Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.Are clinically insignificant prostate cancers really insignificant among Korean men?Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.Incidentally detected inguinoscrotal bladder hernia.Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents.Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.An EEG-based real-time cortical rhythmic activity monitoring system.Incidentally discovered inverted papilloma of the urinary bladder in patients with lower urinary tract symptoms.The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.The effects of long-term androgen deprivation therapy on penile length in patients with prostate cancer: a single-center, prospective, open-label, observational study.Stone heterogeneity index on single-energy noncontrast computed tomography can be a positive predictor of urinary stone composition.Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in KoreaAssociation between urinary hesitancy symptoms and uroflowmetry measured urinary hesitancy time in men with lower urinary tract symptomsAssociation between the neutrophil-to-lymphocyte ratio and intravesical prostatic protrusion in men with benign prostatic hyperplasiaThe Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers
P50
Q26766307-88C9894D-EAE8-4A60-AD1E-C8BE9A928C65Q33735007-98E85BFE-6F30-405F-9EEE-2CF1B4615350Q33892259-4ECECF64-0816-4F53-A273-22ACCE281D87Q34294893-7F935AA3-FC71-4A0B-A76A-F591DAE858EDQ39697907-565C297C-64CC-45A8-AA37-1E6B833A4583Q39921717-4FE6CB1E-9B7E-4656-88B9-E2CA89EF0211Q41328591-52375A97-7C03-4AD2-8F6A-DE45494A970DQ41469996-1D0DDF2C-942D-4CDD-B23D-1C3F5F5FA259Q42595298-3BA34FC5-9376-42AE-B2EC-635A4CAF075AQ47158686-3FD4527F-2C80-432E-BF9D-D53CA334EE3DQ49586737-37B27639-4822-478C-B6C3-C6DC39876CE2Q50916087-4F109166-C7FC-416E-92BC-3E27F0D2B0C6Q51595735-2EABC0F4-CB30-47BE-A33C-2D9E407E5A25Q51710859-1FC22369-D489-4071-B1A2-6C7784E3EE58Q53127352-71F0F6BE-1C4D-40B2-BFAF-E016E5D02D7DQ53418875-24D33E1B-E10C-42A0-854B-77576277E3B1Q54237011-C045EB0F-5E48-4068-A76F-527AC8277C3DQ64057564-84C42299-33A0-43C1-A7E1-1676CAEED306Q83475907-570BD92A-3DB2-4EAB-91C9-4D6982A6142FQ90118465-B9BED72D-4150-4299-BF3D-5F4F32AAA8E5Q92434591-6018A2A6-3820-4852-8D6B-6596C10B828E
P50
description
researcher ORCID ID = 0000-0001-7358-8544
@en
name
Seung Hwan Lee
@ast
Seung Hwan Lee
@en
Seung Hwan Lee
@es
Seung Hwan Lee
@nl
type
label
Seung Hwan Lee
@ast
Seung Hwan Lee
@en
Seung Hwan Lee
@es
Seung Hwan Lee
@nl
prefLabel
Seung Hwan Lee
@ast
Seung Hwan Lee
@en
Seung Hwan Lee
@es
Seung Hwan Lee
@nl
P106
P31
P496
0000-0001-7358-8544